Publications by authors named "M J Osborne"

Despite extensive research on absolute pitch (AP), there remains no gold-standard task to measure its presence or extent. This systematic review investigated the methods of pitch-naming tasks for the classification of individuals with AP and examined how our understanding of the AP phenotype is affected by variability in the tasks used to measure it. Data extracted from 160 studies (N = 23,221 participants) included (i) the definition of AP, (ii) task characteristics, (iii) scoring method, and (iv) participant scores.

View Article and Find Full Text PDF

Background: Individuals with posttraumatic stress disorder (PTSD) have high rates of cardiovascular disease (CVD) and increased cardiometabolic CVD risk factors (CVDRFs, e.g., hypertension, hyperlipidemia, or diabetes mellitus).

View Article and Find Full Text PDF

Objectives: To identify opportunities for improvement in quality of care, we explore Black families' experiences of family support in the neonatal intensive care unit (NICU) during their infant's hospital stay.

Methods: Semistructured qualitative interviews or focus groups (FGs) were conducted to explore Black families' experiences of NICU hospitalization. Inclusion criteria were self-identification as a Black family member and infant admission to our NICU between January 2020 and February 2022.

View Article and Find Full Text PDF

The COVID-19 pandemic accelerated the development of automated systems for detecting molecular targets for the point-of-care. However, these systems have limited multiplexing capabilities because of the need to alter their hardware to accommodate additional targets and probes. Quantum dot barcodes address this multiplexing obstacle, but their assays have multiple steps that rely on extensive training and laboratory equipment.

View Article and Find Full Text PDF

We compare two initial specimen diversion devices evaluated over 3 months to investigate their utility in lowering blood culture contamination rates at or below 1%. Overall contamination rates during trial periods were 2.46% and 2.

View Article and Find Full Text PDF